APOBEC

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description

File:Apobec.J.Steinfeld.D.png
Example of a member of the APOBEC family, APOBEC-2. A cytidine deaminase from Homo sapiens.[1]

Template:Short description

Script error: No such module "Infobox".Template:Template other Template:Pfam box APOBEC ("apolipoprotein B mRNA editing enzyme, catalytic polypeptide") is a family of evolutionarily conserved cytidine deaminases.

Function

A mechanism of generating protein diversity is mRNA editing. The APOBEC family of proteins perform mRNA modifications by deaminating cytidine bases to uracil. The N-terminal domain of APOBEC-like proteins is the catalytic domain, while the C-terminal domain is a pseudocatalytic domain. More specifically, the catalytic domain is a zinc dependent cytidine deaminase domain and is essential for cytidine deamination. The positively charged zinc ion in the catalytic domain attracts to the partial-negative charge of RNA.

In the case of APOBEC-1, the mRNA transcript of intestinal apolipoprotein B is altered. RNA editing by APOBEC-1 requires homodimerization and this complex interacts with RNA-binding proteins to form the editosome.[2] The resulting structure interacts with the codon CAA at codon 2153 and deaminates it into UAA, producing a stop codon that results in mRNA that is translated into the intestinal apoB-48 isoform.[3] For other APOBEC-modified transcripts such as in the site-specific deamination of a CGA to a UGA stop codon in neurofibromatosis type 1 (NF1) mRNA, the resulting proteins are predicted to be truncated as well, although these transcripts are possibly degraded.[4]

C-to-U modifications do not always result in the truncation of proteins. For example, in humans/mammals they help protect from viral infections.[5][6] APOBEC family proteins are widely expressed in cells of the human innate immune system.[7]

Cancer

These enzymes, when misregulated, are a major source of mutation in numerous cancer types.[5][6][8] When the expression of APOBEC family proteins is triggered, accidental mutations in somatic cells can lead to the development of oncogenes, cells which have the potential to develop into a tumor. APOBEC proteins are further expressed in attempt to regulate tumor formation. This makes APOBEC proteins a helpful marker for diagnosing malignant tumors.[9]

Structure

A 2013 review discussed the structural and biophysical aspects of APOBEC3 family enzymes.[10] Many of the APOBEC protein features are described in the widely studied APOBEC3G's page.Template:Tone inline

Family members

Human genes encoding members of the APOBEC protein family include:

References

<templatestyles src="Reflist/styles.css" />

  1. Template:PDB; Script error: No such module "Citation/CS1".; rendered using PyMOL.
  2. Script error: No such module "Citation/CS1".
  3. Script error: No such module "citation/CS1".
  4. Script error: No such module "Citation/CS1".
  5. a b Script error: No such module "citation/CS1".
  6. a b Script error: No such module "Citation/CS1".
  7. Script error: No such module "Citation/CS1".
  8. Script error: No such module "Citation/CS1".
  9. Script error: No such module "citation/CS1".
  10. Script error: No such module "Citation/CS1".

Script error: No such module "Check for unknown parameters".

Bibliography

  • Gupta, A., Gazzo, A., Selenica, P. et al., APOBEC3 mutagenesis drives therapy resistance in breast cancer, Nature Genetics (April 1, 2025) Script error: No such module "CS1 identifiers".

Script error: No such module "InterPro content". Script error: No such module "Navbox". Script error: No such module "Navbox". Template:Portal bar

Template:Asbox